NASDAQ · Medical - Instruments & Supplies

UTMD (UTMD) Stock

$69.10 +2.92% NASDAQ: UTMD Healthcare

Valuation

MetricValue
Price$69.10
Market Cap$220.02M
P/E Ratio18.41
P/B Ratio1.71
P/S Ratio5.44
EPS (TTM)$3.48
52-Week High$76.00
52-Week Low$52.99
Dividend Yield1.92%

Financials & Margins

MetricValue
ROE9.24%
ROA8.94%
ROCE9.17%
Gross Margin30.77%
Operating Margin28.21%
Net Margin28.90%
Debt/Equity0.00
Current Ratio32.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$49.0M$52.0M$50.0M$41.0M$39.0M
Operating Profit$19.0M$20.0M$17.0M$14.0M$11.0M
Net Profit$15.0M$16.0M$17.0M$14.0M$11.0M
EPS$4.04$4.52$4.57$3.96$3.48
Op Margin38.5%37.9%33.4%33.2%29.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$116.0M$124.0M$135.0M$123.0M$123.0M
Total Liabilities$8.0M$10.0M$7.0M$5.0M$3.0M
Cash$61.0M$75.0M$93.0M$83.0M$86.0M
Borrowings$0$0$0$0$0

Latest News

The Zacks Analyst Blog Highlights Berkshire, Eli Lilly, Walmart, Universal Health Realty Income and Utah Zacks · Jun 5, 2026 Top Analyst Reports for Berkshire Hathaway, Eli Lilly & Walmart Zacks · Jun 4, 2026 Utah Medical Products, Inc. Announces Quarterly Dividend ACCESS Newswire · May 5, 2026 Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs Zacks · Apr 29, 2026 Utah Medical: Q1 Earnings Snapshot Associated Press · Apr 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$21.0M$21.0M$22.0M$15.0M$15.0M
Investing Cash Flow$-1.0M$-2.0M$-1.0M$0$-1.0M
Financing Cash Flow$1.0M$-2.0M$0$-20.0M$-8.0M
Net Cash Flow$9.0M$14.0M$18.0M$-10.0M$3.0M
Free Cash Flow$21.0M$20.0M$22.0M$15.0M$14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA8.43
FCF Yield6.37%
Quick Ratio26.15
Interest Coverage—
Return 1Y12.51%
Return 3Y-28.87%
Return 5Y-12.28%

Ownership

Insiders Held7.18%
Institutions Held75.19%
Institutions Float Held81.00%
Institutional HolderSharesReport Date
Brandes Investment Partners L.P.449,2792026-03-31
Dimensional Fund Advisors LP197,9082026-03-31
Blackrock Inc.187,6492026-03-31
Renaissance Technologies, LLC184,1142026-03-31
Vanguard Capital Management LLC138,5602026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CATX $3.00 +1.01% -2.59 $342.14M 0.00%
CHRS $1.27 +0.40% -2.21 $155.46M 0.00%
INFU $9.92 +5.98% 32.90 $200.20M 0.00%
KRMD $4.11 +0.00% -67.33 $188.78M 0.00%
NYXH $1.41 -2.76% -1.23 $55.85M 0.00%

About UTMD

UTMD is led by CEO Kevin L. Cornwell, employs 155 people, headquartered in US, publicly traded since 1999.

UTMD stock trades at $69.10 with a market capitalization of $220.02M. The stock is valued at a price-to-earnings (P/E) ratio of 18.41, price-to-book of 1.71, price-to-sales of 5.44. Over the past 52 weeks the stock has ranged between $52.99 and $76.00, and currently trades 9.1% below its 52-week high. It pays a dividend yielding 1.92%.

On profitability, UTMD generates a return on equity (ROE) of 9.24%, return on capital employed of 9.17%, an operating margin of 28.21%, a net profit margin of 28.90%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides